Electromyography Devices Market Research, 2031
The global electromyography devices market size was valued at $786.0 million in 2021 and is projected to reach $1.648.7 million by 2031, growing at a CAGR of 7.9% from 2022 to 2031. Electromyography devices are used for the diagnosis of neuromuscular diseases. Neuromuscular disorders affect the nerves that control voluntary muscles and the nerves that communicate sensory information back to the brain. When the neurons become unhealthy, communication between the nervous system and muscles breaks down. As a result, muscles weaken and causes various neuromuscular disorder including muscular dystrophies, distal myopathies, congenital myopathies, myotonic dystrophy, myotonia congenita, primary periodic paralysis, inflammatory muscle diseases, progressive metabolic myopathies, neuromuscular junction diseases, spinal muscular atrophy, and hereditary neuropathies. Electromyography devices measure the electrical signal that causes muscles to contract and relax and act as biofeedback devices. Two types of electromyography devices include stationary electromyography devices, and portable electromyography devices that are used for the study of nerve conduction, and needle electrode examination.
Growth & innovations in the pharmaceutical industry for the manufacturing of electromyography devices owing to a massive pool of health-conscious consumers creates an opportunity for the electromyography devices market.
The growth of the electromyography devices market share is expected to be driven by the high potential in untapped, emerging markets, due to the availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of neuromuscular diseases, and surge in demand for electromyography devices. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to the rise in demand for enhanced healthcare services, significant investments by the government to improve healthcare infrastructure, and the development of the medical tourism industry in emerging countries. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to the rise in the preference of consumers for online shopping over traditional purchasing methods. This is attributed to further support market growth.
The electromyography device market has witnessed growth owing to the rise in the prevalence of neuromuscular diseases such as muscular dystrophies, distal myopathies, congenital myopathies, myotonic dystrophy, myotonia congenita, primary periodic paralysis, inflammatory muscle diseases, progressive myositis ossificans, metabolic myopathies, neuromuscular junction diseases, spinal muscular atrophy, and hereditary neuropathies further drive the growth of the market. For instance, according to Alzheimer’s Society, it is estimated that about 5.8 million people in the U.S. aged 65 years and above were affected by Alzheimer’s dementia in 2020. The demand for electromyography devices is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuel the growth of the market. Factors such as the rise in electromyography devices, and an increase in awareness toward electromyography devices, further drive the growth of the market. Moreover, an increase in promotional activities by manufacturers and a rise in consumer awareness related to preventive healthcare and ease of accessibility are expected to fuel their adoption in the near future.
Segmental Overview
The EMG devices market size is segmented on the basis of product, study type, end user, and region. On the basis of product, the market is classified into stationary EMG systems and portable EMG systems. On the basis of study type, the market is classified into nerve conduction, and needle electrode examination (NEE). Depending on the end user, it is fragmented into clinics, hospitals, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Product Type
Based on product type, the market is classified into stationary EMG systems and portable EMG systems. The stationary EMG systems segment generated maximum revenue in 2021, and is expected to witness the highest CAGR during the Electromyography Devices Market forecast period, owing to an increase in the prevalence of neuromuscular diseases, high adoption of stationary EMG systems for the diagnosis of neurovascular diseases, and an increase in technological advancements in stationary EMG systems.
By Study Type
Based on study type, Electromyography devices market is segregated into nerve conduction, and needle electrode examination (NEE). The nerve conduction segment generated maximum revenue in 2021 and is expected to witness the highest CAGR during the forecast period, owing to the rise in prevalence of neurological and muscular disorders, increase in investment in research studies, and increase in the use of nerve conduction studies. Growth of the nerve conduction segment is also associated with an increase in cases of sciatic nerve problems, and chronic inflammatory polyneuropathy, which leads to an increase in the use of nerve conduction studies for diagnosis and boosts the growth of the nerve conduction segments.
By End User
The market is classified into clinics, hospitals, and others. The hospital segment was the highest revenue contributor to the market in 2021, owing to an increase in patient admission in hospitals, and the availability of trained medical staff in hospitals that helps to provide better services to patients. The clinic segment is expected to witness the highest CAGR during the forecast period, owing to an increase in the geriatric population that is more prone to neuromuscular disease, and an increase in the number of Alzheimer's and Parkinson's diseases. The rise in healthcare expenditure also boosts the growth of the clinic segment in the electromyography devices market.
By Region
The electromyography devices market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the electromyography devices Market in 2021 and is expected to maintain its dominance during the forecast period.
The presence of several major players, such as Biometrics Ltd, Cadwell Industries Inc., Natus Medical Incorporated, and Noraxon USA Inc., and advancement in technology of electromyography devices in the region drive the growth of the market. In addition, surge in ÑоnÑеrn аmоng реорlе for mаіntаіnÑ–ng hеаlth and ÑоnÑ•Ñ–Ñ•tеnt grоwth in the gеrіаtrÑ–Ñ Ñ€Ð¾Ñ€ulаtіоn, Ñ–nÑrеаѕеѕ the demand for electromyography devices in the region, which is ехреÑtеd to Ñ€rореl the grоwth of the market. Furthermore, the presence of well-established healthcare infrastructure, high purchasing power, and a rise in the adoption rate of electromyography devices are expected to drive the Electromyography Devices Market growth. Furthermore, product launches, mergers, collaborations, and acquisitions adopted by the key players in this region boost the growth of the market. For instance, in January 2022, Cadwell Industries Inc. announced the launch of new electromyography (EMG) product, a Pudendal (Pelvic Floor) Stimulating and Recording Electrode used for evaluating the pudendal nerve terminal motor latency (PNTML). The launch of Pudendal Stimulating and Recording Electrode will help the company to strengthen its EMG product portfolio.
Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of electromyography device manufacturing companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, the rise in healthcare expenditure and the adoption of high-tech processing to improve the production of electromyography devices, drive the growth of the market. Furthermore, the rise geriatric population is more vulnerable to neuromuscular diseases. For instance, according to research published by the WHO, China, India, and their South-Asian and Western-Pacific countries are witnessing considerable growth in the elderly population. The aging population also increases the risk of chronic diseases are one of the biggest healthcare concerns in the world, claiming an estimated 40 million lives every year, 8.5 million of whom reside in Asia. For instance, according to a report published by, UNFPA Asia-Pacific it was estimated that the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 out of which women constitute the majority of the population aged 60 or older in the region and share rises to 60 percent above age 80 This, in turn, drives the growth of the market. Asia-Pacific offers profitable opportunities for key players operating in the electromyography devices market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as the well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunities for new entrants in this region.
COMPETITION ANALYSIS
Competitive analysis and profiles of the major players in the electromyography devices market, such as ADInstruments, Biometrics Ltd, Cadwell Industries Inc., Clarity Medical Pvt. Ltd., Cometa SRL, Compumedics Limited, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, and Noraxon USA Inc. are provided in this report. There are some important players in the market such as Medtronic plc, Cadwell Industries Inc., and others. Major players have adopted product launch, and product approval as key developmental strategies to improve the product portfolio of the electromyography devices market.
Some examples of strategic initiatives in the market
In January 2022, Cadwell Industries Inc. announced the launch of new electromyography (EMG) product, Pudendal (Pelvic Floor) Stimulating and Recording Electrode used for evaluating the pudendal nerve terminal motor latency (PNTML). The launch of Pudendal Stimulating and Recording Electrode will help the company to strengthen its EMG product portfolio.
Product approval in the market
In October 2020, Medtronic plc has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables physicians to identify, confirm, and monitor nerve functions. The approval of NIM Vital System will help the company to strengthen its ENT portfolio.
Acquisition in the market
In September 2022, Compumedics acquired an initial 50% interest in Alpha Trace, as the Company believes it will provide the two following significant benefits; Firstly, it will strengthen the selling infrastructure in this part of Europe as Alpha Trace, being part of the transaction, will have access to Compumedics’ existing range of products for sale into the region. The second is that Alpha Trace currently has an EMG device that is complementary to Compumedics’ existing neuro-diagnostic product range, a neuro-muscular diagnostic technology, that our neurodiagnostic customers often request and one that Compumedics has not had up until this point.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current Electromyography Devices Market trends, estimations, and dynamics of the Electromyography Devices Market analysis from 2021 to 2031 to identify the prevailing electromyography devices market opportunities.
- Market research is offered along with information related to key drivers, restraints, and Electromyography Devices Market opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- An in-depth analysis of the electromyography devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional as well as global electromyography devices market trends, key players, market segments, application areas, and Electromyography Devices industry growth strategies.
Electromyography Devices Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 1.7 billion |
 Growth Rate | CAGR of 7.9% |
 Forecast period | 2021 - 2031 |
 Report Pages | 224 |
 By Product |
|
 By Study Type |
|
 By End-User |
|
 By Region |
|
 Key Market Players | COMETA SRL, AD Instruments, Natus Medical Incorporated, NORAXON USA INC, CADWELL INDUSTRIES INC, IDscan Biometrics Ltd., Medtronic plc, NIHON KOHDEN CORPORATION, compumedics limited - official, CLARITY MEDICAL PVT. LTD |
Analyst Review
This section provides opinions of top-level CXOs in the electromyography devices market. The use of electromyography devices has a positive effect on diagnoses of neuromuscular diseases, such as Parkinson's and Alzheimer's disease.
The electromyography devices market has gained the interest of the healthcare industry, owing to a rise in a number of chronic diseases such as muscular dystrophies, distal myopathies, congenital myopathies, myotonic dystrophy, myotonia congenita, primary periodic paralysis, inflammatory muscle diseases, progressive myositis ossificans, metabolic myopathies, neuromuscular junction diseases, spinal muscular atrophy, and hereditary neuropathies. In addition, an increase in the number of geriatric populations suffering from Parkinson's and Alzheimer's disease leads to high adoption of electromyography (EMG) devices, which are expected to significantly boost the growth of the electromyography devices market. However, the high cost of EMG devices restricts the growth of the market. On the contrary, unmet medical demands in developing countries are expected to provide remunerative opportunities for market expansion
North America is expected to witness the highest growth, in terms of revenue, owing to the presence of robust healthcare infrastructure, the presence of key players, and rise in healthcare expenditure. However, Asia-Pacific is anticipated to witness notable growth, owing to a rise in geriatric population that are vulnerable to neuromuscular diseases, unmet medical demands, rise in awareness regarding the use of electromyography devices in diagnosis of neuromuscular diseases, and increase in public–private investments in the healthcare sector.
The utilization of EMG devices for athletes is one of the novel trends in the Electromyography Devices Market
Asia-Pacific is expected to grow at the highest rate during the forecast period.
North America accounted for a major share of the electromyography devices Market in 2021 and is expected to maintain its dominance during the forecast period.
The electromyography devices market was valued at $786 million in 2021, and is estimated to reach $ 1648.7 million by 2031, growing at a CAGR of 7.9% from 2022 to 2031.
Medtronic plc, Nihon Kohden Corp, Compumedics Limited, Natus Medical Inc., Noraxon USA Inc., Cadwell Industries Inc. and Cometa SRL are few major companies operating in Electromyography Devices Market
Increase in the prevalence of neuromuscular diseases and Rise in demand for non-invasive diagnostic techniques for neuromuscular diseases are two major drivers driving the market growth
Stringent government regulations coupled with the dearth of skilled professionals is one of the major factors restricting market growth.
Yes
Loading Table Of Content...
